Asia-Pacific: Market for Medicaments Of Alkaloids Or Derivatives Thereof 2024

Market Size for Medicaments Of Alkaloids Or Derivatives Thereof in Asia-Pacific

The Asia-Pacific market for medicaments of alkaloids or derivatives thereof reached $X in 2022, approximately equating the previous year. The total consumption indicated tangible growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption increased by X% against 2015 indices. Over the period under review, the market reached the peak level in 2022 and is expected to retain growth in the immediate term.

Production of Medicaments Of Alkaloids Or Derivatives Thereof in Asia-Pacific

In value terms, production of medicaments of alkaloids or derivatives thereof shrank modestly to $X in 2022 estimated in export price. The total production indicated notable growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2019 indices. The growth pace was the most rapid in 2018 when the production volume increased by X% against the previous year. The level of production peaked at $X in 2019; however, from 2020 to 2022, production stood at a somewhat lower figure.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Exports of Medicaments Of Alkaloids Or Derivatives Thereof

Exports in Asia-Pacific

Exports of medicaments of alkaloids or derivatives thereof reduced modestly to X tons in 2022, waning by X% on the previous year. In general, exports showed a abrupt downturn. The growth pace was the most rapid in 2019 with an increase of X% against the previous year. Over the period under review, the exports of attained the maximum at X tons in 2012; however, from 2013 to 2022, the exports failed to regain momentum.

In value terms, exports of medicaments of alkaloids or derivatives thereof rose notably to $X in 2022. Over the period under review, exports saw a dramatic descent. The most prominent rate of growth was recorded in 2019 when exports increased by X% against the previous year. The level of export peaked at $X in 2012; however, from 2013 to 2022, the exports failed to regain momentum.

Exports by Country

Hong Kong SAR was the major exporting country with an export of around X tons, which resulted at X% of total exports. It was distantly followed by New Zealand (X tons), mixing up a X% share of total exports. Australia (X tons), Pakistan (X tons) and India (X tons) held a minor share of total exports.

Exports from Hong Kong SAR decreased at an average annual rate of X% from 2012 to 2022. At the same time, New Zealand (X%) and Pakistan (X%) displayed positive paces of growth. Moreover, New Zealand emerged as the fastest-growing exporter exported in Asia-Pacific, with a CAGR of X% from 2012-2022. By contrast, Australia (X%) and India (X%) illustrated a downward trend over the same period. While the share of Hong Kong SAR (X p.p.), New Zealand (X p.p.), Pakistan (X p.p.) and Australia (X p.p.) increased significantly in terms of the total exports from 2012-2022, the share of India (X p.p.) displayed negative dynamics.

In value terms, Hong Kong SAR ($X) remains the largest medicaments of alkaloids or derivatives thereof supplier in Asia-Pacific, comprising X% of total exports. The second position in the ranking was taken by New Zealand ($X), with an X% share of total exports. It was followed by Australia, with a X% share.

In Hong Kong SAR, exports of medicaments of alkaloids or derivatives thereof expanded at an average annual rate of X% over the period from 2012-2022. In the other countries, the average annual rates were as follows: New Zealand (X% per year) and Australia (X% per year).

Export Prices by Country

In 2022, the export price in Asia-Pacific amounted to $X per ton, growing by X% against the previous year. In general, the export price, however, continues to indicate a pronounced slump. The most prominent rate of growth was recorded in 2021 when the export price increased by X% against the previous year. The level of export peaked at $X per ton in 2013; however, from 2014 to 2022, the export prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Australia ($X per ton), while Pakistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Hong Kong SAR (X%), while the other leaders experienced a decline in the export price figures.

Imports of Medicaments Of Alkaloids Or Derivatives Thereof

Imports in Asia-Pacific

In 2022, approx. X tons of medicaments of alkaloids or derivatives thereof were imported in Asia-Pacific; surging by X% against 2021 figures. Overall, imports, however, recorded a abrupt contraction. The most prominent rate of growth was recorded in 2018 when imports increased by X% against the previous year. The volume of import peaked at X tons in 2012; however, from 2013 to 2022, imports failed to regain momentum.

In value terms, imports of medicaments of alkaloids or derivatives thereof expanded modestly to $X in 2022. In general, imports, however, showed a mild contraction. The pace of growth was the most pronounced in 2014 with an increase of X% against the previous year. As a result, imports reached the peak of $X. From 2015 to 2022, the growth of imports of failed to regain momentum.

Imports by Country

Japan (X tons), Australia (X tons) and South Korea (X tons) represented roughly X% of total imports in 2022. It was distantly followed by Malaysia (X tons), constituting a X% share of total imports. The following importers - Indonesia (X tons), New Zealand (X tons) and Hong Kong SAR (X tons) - together made up X% of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main importing countries, was attained by New Zealand (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments of alkaloids or derivatives thereof importing markets in Asia-Pacific were Malaysia ($X), Japan ($X) and Australia ($X), together accounting for X% of total imports.

Japan, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Asia-Pacific stood at $X per ton in 2022, rising by X% against the previous year. Import price indicated a resilient increase from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, import price for medicaments of alkaloids or derivatives thereof increased by X% against 2017 indices. The pace of growth appeared the most rapid in 2015 when the import price increased by X% against the previous year. Over the period under review, import prices hit record highs in 2022 and is likely to see steady growth in the immediate term.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Malaysia ($X per ton), while Hong Kong SAR ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Malaysia (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :